☆ 4.5 Letter

Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias

BONE MARROW TRANSPLANTATION (2004)

Get Full Text
Add to Collection

Journal

BONE MARROW TRANSPLANTATION
Volume 34, Issue 9, Pages 827-828

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bmt.1704687

Keywords

-

Categories

Biophysics Oncology Hematology Immunology Transplantation

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.